-%

State of Delaware
Secre of State
Division of Co rations
Delivered 05:02 PM 03/17/2010
FILED 04:59 PM 03/17/2010
SRV 100290615 - 3670071 FILE

CERTIFICATE OF AMENDMENT
OF
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
OF

ACCELERON PHARMA INC.

Acceleron Pharma Inc. (the “Corporation”), a corporation organized and existing under
and by virtue of the General Corporation Law of the State of Delaware, does hereby certify as
follows:

1, This Corporation’s original Certificate of Incorporation was filed with the
Secretary of State of Delaware on June 13, 2003 under the name “phoenix pharma, Inc.”

2. This Corporation’s Certificate of Incorporation was amended and restated on
February 4, 2004.

3. This Corporation’s Amended and Restated Certificate of Incorporation was
further amended on July 20, 2004 and December 19, 2005 and amended and restated on July 28,
2006, and further amended and restated on October 23, 2007 and March 10, 2008 and restated on
March 24, 2008, and further amended on June 25, 2009 and November 6, 2009, and further
amended and restated on December 3, 2009.

4. This Certificate of Amendment has been duly adopted by this Corporation’s
Board of Directors and stockholders in accordance with the applicable provisions of Sections
228 and 242 of the General Corporation Law of the State of Delaware.

5. The first paragraph of Article FOURTH of the Certificate of Incorporation of the
Corporation is hereby amended to read in its entirety as follows:

FOURTH: The total number of shares of all classes of stock which the
Corporation has authority to issue is 144,651,161 shares, consisting of 83,941,112 shares
of Common Stock, par value $.001 per share (the “Common Stock”), 26,069,980 shares
of Series A Convertible Preferred Stock, par value $.001 per share (the “Series A
Preferred Stock”), 16,944,378 shares of Series B Convertible Preferred Stock, par value
$.001 per share (the “Series B Preferred Stock”), 11,923,077 shares of Series C
Convertible Preferred Stock, par value $.001 per share (the “Series C Stock”), 2,014,652
shares of Series C-1 Convertible Preferred Stock. par value $.001 per share (the “Series
C-1 Stock” and, together with the Senes C Stock, the “Series C Preferred Stock”’),
955,414 shares of Series D Convertible Preferred Stock, par value $.001 per share (the
“Series D Stock”), 2.802,548 shares of Series D-1 Convertible Preferred Stock, par value
$.001 per share (the “Series D-1 Stock” and, together with the Series D Stock, the “Series

24367665_4.DOC

D Preferred Stock”). The Series A Preferred Stock, the Series B Preferred Stock, the
Series C Preferred Stock and the Series D Preferred Stock are referred to herein as the
“Preferred Stock”).

[remainder of page intentionally left blank]

24367665_4.DOC


IN WITNESS WHEREOF, the undersigned has executed this Certificate of Amendment
as ofthe 27*hdayof_ watch _, 2010.

By:

